The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Marie-Christine Vantyghem

Endocrinologie et Métabolisme

hôpital Huriez

Institut National de la Santé et de la Recherche Médicale Unité 859

Centre Hospitalier et Universitaire de Lille

France

[email]@chru-lille.fr

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Endocrinologie et Métabolisme, hôpital Huriez, Institut National de la Santé et de la Recherche Médicale Unité 859, Centre Hospitalier et Universitaire de Lille, France. 2012
  • Unit of Endocrinology and Metabolism, Endocrine Surgery and Nephrology Department, Lille University Hospital, Lille, France -. 2003 - 2011
  • INSERM U 859, Diabetes Cell Therapy Lille University Hospital, Lille Cedex, France. 2009
  • Service d'Endocrinologie-Métabolisme Clinique Linquette, Centre Hospitalier Régional et Universitaire de Lille, 6 Rue du Pr Laguesse, Lille, France. 2008

References

  1. Continuous Glucose Monitoring after Islet Transplantation in Type 1 Diabetes: An Excellent Graft Function (β-Score Greater Than 7) Is Required to Abrogate Hyperglycemia, Whereas a Minimal Function Is Necessary to Suppress Severe Hypoglycemia (β-Score Greater Than 3). Vantyghem, M.C., Raverdy, V., Balavoine, A.S., Defrance, F., Caiazzo, R., Arnalsteen, L., Gmyr, V., Hazzan, M., Noël, C., Kerr-Conte, J., Pattou, F. J. Clin. Endocrinol. Metab. (2012) [Pubmed]
  2. Diabetes cell therapy: a decade later. Vantyghem, M.C., Balavoine, A.S., Caiazzo, R., Kerr-Conte, J., Noel, C., Pattou, F. Minerva Endocrinol. (2011) [Pubmed]
  3. Intraperitoneal insulin infusion versus islet transplantation: comparative study in patients with type 1 diabetes. Vantyghem, M.C., Marcelli-Tourvieille, S., Fermon, C., Duhamel, A., Raverdy, V., Arnalsteen, L., Kerr-Conte, J., Noel, C., Fontaine, P., Pattou, F. Transplantation (2009) [Pubmed]
  4. Who should benefit from diabetes cell therapy? Vantyghem, M.C., Balavoine, A.S., Kerr-Conte, J., Pattou, F., Noel, C. Ann. Endocrinol. (Paris) (2009) [Pubmed]
  5. Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy. Vantyghem, M.C., Vincent-Desplanques, D., Defrance-Faivre, F., Capeau, J., Fermon, C., Valat, A.S., Lascols, O., Hecart, A.C., Pigny, P., Delemer, B., Vigouroux, C., Wemeau, J.L. J. Clin. Endocrinol. Metab. (2008) [Pubmed]
  6. Effects of non-steroid immunosuppressive drugs on insulin secretion in transplantation. Vantyghem, M.C., Marcelli-Tourvielle, S., Pattou, F., Noël, C. Ann. Endocrinol. (Paris) (2007) [Pubmed]
  7. Familial partial lipodystrophy due to the LMNA R482W mutation with multinodular goitre, extrapyramidal syndrome and primary hyperaldosteronism. Vantyghem, M.C., Faivre-Defrance, F., Marcelli-Tourvieille, S., Fermon, C., Evrard, A., Bourdelle-Hego, M.F., Vigouroux, C., Defebvre, L., Delemer, B., Wemeau, J.L. Clin. Endocrinol. (Oxf) (2007) [Pubmed]
  8. Calcitonin levels do not decrease with weaning in chronic alcoholism. Vantyghem, M.C., Danel, T., Marcelli-Tourvieille, S., Moriau, J., Leclerc, L., Cardot-Bauters, C., Docao, C., Carnaille, B., Wemeau, J.L., D'Herbomez, M. Thyroid (2007) [Pubmed]
  9. Phenotype and HFE genotype in a population with abnormal iron markers recruited from an Endocrinology Department. Vantyghem, M.C., Fajardy, I., Dhondt, F., Girardot, C., D'Herbomez, M., Danze, P.M., Rousseaux, J., Wemeau, J.L. Eur. J. Endocrinol. (2006) [Pubmed]
  10. Management strategies for brittle diabetes. Vantyghem, M.C., Press, M. Ann. Endocrinol. (Paris) (2006) [Pubmed]
  11. Eligibility of diabetic patients receiving dialysis for islet after kidney transplantation. Vantyghem, M.C., Pattou, F., Girardot, C., Soudan, B., Hazzan, M., Noel, C. Transplant. Proc. (2004) [Pubmed]
  12. Eligibility of diabetic patients for islet transplantation alone. Vantyghem, M.C., Perimenis, P., Tourvieille, S., Touzet, L., Pattou, F. Transplant. Proc. (2004) [Pubmed]
  13. Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities. Vantyghem, M.C., Pigny, P., Maurage, C.A., Rouaix-Emery, N., Stojkovic, T., Cuisset, J.M., Millaire, A., Lascols, O., Vermersch, P., Wemeau, J.L., Capeau, J., Vigouroux, C. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  14. Thyroid carcinomas involving follicular and parafollicular C cells: seventeen cases with characterization of RET oncogenic activation. Vantyghem, M.C., Pigny, P., Leteurtre, E., Leclerc, L., Bauters, C., Douillard, C., D'Herbomez, M., Carnaille, B., Proye, C., Wemeau, J.L., Lecomte-Houcke, M. Thyroid (2004) [Pubmed]
  15. Kinetics of diabetes-associated autoantibodies after sequential intraportal islet allograft associated with kidney transplantation in type 1 diabetes. Vantyghem, M.C., Fajardy, I., Pigny, P., Noel, C., Kerr-Conte, J., Gmyr, V., Vandewalle, B., Proye, C., Pattou, F. Diabetes Metab. (2003) [Pubmed]
 
WikiGenes - Universities